Log In
Print this Print this

TT-063 Patch, S-flurbiprofen

  Manage Alerts
Collapse Summary General Information
Company Taisho Pharmaceutical Holdings Co. Ltd.
DescriptionPatch formulation containing S-flurbiprofen
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA)
Regulatory Designation
PartnerTeijin Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today